To further investigate the relationship between T14 and its target receptor in a clinically relevant experimental paradigm, we used western blotting to determine the levels of T14 and α7 nAChR in post-mortem human brain from AD patients. The gene discussed is CHRNA7; the disease is Alzheimer disease.